Vaccine disease awareness strategy

The challenge

A Global Medical Affairs infectious disease team wanted to understand and leverage key learnings from Disease Awareness campaigns and related pre-launch/launch activities of relevant analog vaccines. These learnings would then inform a global pre-launch strategy for a vaccine in clinical development.

The approach

Vynamic’s approach combined our subject-matter expertise and insight with robust methodology and collaborative client partnership. We created strategic recommendations to guide the client team’s future global strategy. Our stepwise approach included:

Methodology for primary and secondary research​
Interviewed internal experts, researched additional secondary sources, and assessed strategic gaps.​

Disease awareness overview​
Analyzed the Disease Awareness landscape for each of the analogs, both before and after each vaccine launched​.

Review of market access, regulation, and policy​
Reviewed and assessed additional key topics of interest that would impact the client’s strategic planning.​

Conclusions and strategic recommendations​
Distilled key conclusions for each analog and developed strategic recommendations related for the client team to take forward to senior leadership.​

The results

Overall, our partnership with the client was positive from beginning to end, and our clients remarked how engaging and collaborative an experience it was. Vynamic’s unique approach helped the client team understand the key historical events and challenges to help them preempt and mitigate as part of their future strategy for launch. Our clients shared their intent to utilize our work cross-functionally given its high relevance and impact for their future global discussions and planning, meetings, and decisions. Due to this work, our clients have been armed with a key input needed to inform their future strategic options.